RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sheila Watson

Family · Valparaiso, INNPI 1043614035

Payments from drug & device makers

$2,448in general payments, 2019–2025

Across 80 payments — averaging $30.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$489
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$258
  • Alkermes, Inc.$233
  • Neurocrine Biosciences, Inc.$205
  • Axsome Therapeutics, Inc.$205
  • Corium, LLC$165
  • plus $893 from 19 others

What the payments were for

  • Food & beverage$2,448100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Otsuka America Pharmaceutical, Inc.11$489
Otsuka Pharmaceutical Development & Commercialization, Inc.3$258
Alkermes, Inc.8$233
Neurocrine Biosciences, Inc.6$205
Axsome Therapeutics, Inc.3$205
Corium, LLC7$165
AbbVie6$156
Teva Pharmaceuticals USA, Inc.7$120
Johnson & Johnson4$109
Gilead1$80
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$70
Idorsia Pharmaceuticals US Inc3$53
Novo Nordisk2$39
Noven Therapeutics, LLC2$34
Insulet Corporation1$33
AstraZeneca2$30
E.r. Squibb & Sons, L.L.C.1$24
Phathom Pharmaceuticals, Inc.2$23
Bayer1$22
Lundbeck LLC1$20
Novartis1$19
Boehringer Ingelheim1$16
Dexcom, Inc.1$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$15
Paratek Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,448 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$200

Paid to pharmacies, not to this prescriber.

Other family in Valparaiso

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →